Eezysun Aloe Vera After Sun

Aniba Rosaedora, Calendula Officinails, Hyaluronic Acid, Lavandula Officinalis, Matricaria Chamomilla, Mentha Piperita


Bio Earth Manufacturing (pty) Ltd
Human Otc Drug
NDC 70116-011
Eezysun Aloe Vera After Sun also known as Aniba Rosaedora, Calendula Officinails, Hyaluronic Acid, Lavandula Officinalis, Matricaria Chamomilla, Mentha Piperita is a human otc drug labeled by 'Bio Earth Manufacturing (pty) Ltd'. National Drug Code (NDC) number for Eezysun Aloe Vera After Sun is 70116-011. This drug is available in dosage form of Gel. The names of the active, medicinal ingredients in Eezysun Aloe Vera After Sun drug includes Aniba Rosaeodora Whole - .1 g/100mL Calendula Officinalis Flowering Top - .1 g/100mL Hyaluronic Acid - .5 g/100mL Lavandula Angustifolia Subsp. Angustifolia Flower - .3 g/100mL Matricaria Chamomilla Whole - .4 g/100mL Mentha X Piperita Whole - .15 g/100mL . The currest status of Eezysun Aloe Vera After Sun drug is Active.

Drug Information:

Drug NDC: 70116-011
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Eezysun Aloe Vera After Sun
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Aniba Rosaedora, Calendula Officinails, Hyaluronic Acid, Lavandula Officinalis, Matricaria Chamomilla, Mentha Piperita
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Bio Earth Manufacturing (pty) Ltd
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Gel
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ANIBA ROSAEODORA WHOLE - .1 g/100mL
CALENDULA OFFICINALIS FLOWERING TOP - .1 g/100mL
HYALURONIC ACID - .5 g/100mL
LAVANDULA ANGUSTIFOLIA SUBSP. ANGUSTIFOLIA FLOWER - .3 g/100mL
MATRICARIA CHAMOMILLA WHOLE - .4 g/100mL
MENTHA X PIPERITA WHOLE - .15 g/100mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 26 Mar, 2021
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 14 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:BIO EARTH MANUFACTURING (PTY) LTD
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:5ZTZ6VF78R
18E7415PXQ
S270N0TRQY
19AH1RAF4M
G0R4UBI2ZZ
79M2M2UDA9
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
70116-011-01100 mL in 1 TUBE (70116-011-01)26 Mar, 2021N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose relaxing, cooling, anti-inflammatory, soothing, relieving

Product Elements:

Eezysun aloe vera after sun aniba rosaedora, calendula officinails, hyaluronic acid, lavandula officinalis, matricaria chamomilla, mentha piperita aloe vera leaf polysaccharides rosewood oil carbomer homopolymer, unspecified type ethylhexylglycerin glycerin peppermint oil phenoxyethanol hyaluronate sodium sodium hydroxide water aniba rosaeodora whole aniba rosaeodora whole calendula officinalis flowering top calendula officinalis flowering top hyaluronic acid hyaluronic acid lavandula angustifolia subsp. angustifolia flower lavandula angustifolia subsp. angustifolia flower matricaria chamomilla whole matricaria chamomilla mentha x piperita whole mentha piperita

Indications and Usage:

Uses cooling down the skin

Warnings:

Warnings for external use only. not suitable for epileptics not suitable for people with uncontrolled hyper-tension. not recommended during pregnancy and lactation not suitable for individuals with known sensitivity to any of the ingredients. avoid contact with eyes.

Dosage and Administration:

Directions adults: apply up to three times per day as needed children: use conservatively for children younger than two years

Package Label Principal Display Panel:

Product label image description


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.